# Botulinum A Toxin in Patients With Parkinson's Disease

> **NCT00822913** · PHASE4 · UNKNOWN · sponsor: **University Of Perugia** · enrollment: 20 (estimated)

## Conditions studied

- Parkinson's Disease
- Multiple System Atrophy
- Detrusor Overactivity

## Interventions

- **DRUG:** Intravesical injection of Botulinum A toxin

## Key facts

- **NCT ID:** NCT00822913
- **Lead sponsor:** University Of Perugia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-06
- **Primary completion:** 2008-12
- **Final completion:** 2009-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2009-01-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00822913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00822913, "Botulinum A Toxin in Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00822913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*